rs1106679
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006035.4(CDC42BPB):c.176-7127T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 152,076 control chromosomes in the GnomAD database, including 5,931 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 5931 hom., cov: 32)
Consequence
CDC42BPB
NM_006035.4 intron
NM_006035.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.687
Publications
7 publications found
Genes affected
CDC42BPB (HGNC:1738): (CDC42 binding protein kinase beta) This gene encodes a member of the serine/threonine protein kinase family. The encoded protein contains a Cdc42/Rac-binding p21 binding domain resembling that of PAK kinase. The kinase domain of this protein is most closely related to that of myotonic dystrophy kinase-related ROK. Studies of the similar gene in rat suggested that this kinase may act as a downstream effector of Cdc42 in cytoskeletal reorganization. [provided by RefSeq, Jul 2008]
CDC42BPB Gene-Disease associations (from GenCC):
- Chilton-Okur-Chung neurodevelopmental syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.489 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDC42BPB | NM_006035.4 | c.176-7127T>C | intron_variant | Intron 1 of 36 | ENST00000361246.7 | NP_006026.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.217 AC: 33024AN: 151958Hom.: 5904 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33024
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.218 AC: 33108AN: 152076Hom.: 5931 Cov.: 32 AF XY: 0.213 AC XY: 15814AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
33108
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
15814
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
20501
AN:
41438
American (AMR)
AF:
AC:
2210
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
554
AN:
3468
East Asian (EAS)
AF:
AC:
70
AN:
5180
South Asian (SAS)
AF:
AC:
252
AN:
4814
European-Finnish (FIN)
AF:
AC:
1438
AN:
10594
Middle Eastern (MID)
AF:
AC:
46
AN:
292
European-Non Finnish (NFE)
AF:
AC:
7558
AN:
67980
Other (OTH)
AF:
AC:
386
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1105
2210
3316
4421
5526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
247
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.